B Group, Inc.
Filing Date
Global Rank
#4,728
/ 8,232
▲ 268
Top Industry
Biotechnology
97.3%
3Y Alpha vs SPY
-1.8%
Period ended 2 months ago
Filed May 15, 2026 · 30d
6 quarters · since Dec 2024
Clone Performance
Feb 2025–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+21.3%
SPY
+23.4%
Annualised alpha
-1.5%
Max drawdown
−32.8%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
20 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
21.4%
−11.7 pts
Top 5
58.2%
−9.0 pts
Top 10
81.1%
−8.8 pts
HHI
1,003
Diversified−523
Portfolio Trend
6 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $134,887,408 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
6 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| PALI | Palisade Bio, Inc. | +6,914,285 | 11,414,285 | $19,974,998 | |
| ADMA | Adma Biologics, Inc. | +750,000 | 3,207,542 | $28,899,953 | |
| ZLAB | Zai Lab Ltd | +50,646 | 450,646 | $8,476,651 | |
| SGHT | Sight Sciences, Inc. | +50,000 | 970,000 | $3,656,900 | |
| GPCR | Structure Therapeutics Inc. | +37,500 | 127,500 | $6,145,500 | |
| AURA | Aura Biosciences, Inc. | +25,000 | 597,576 | $3,997,783 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
4 positions
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
20 positions ·
$134,887,408 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ADMA |
Adma Biologics, Inc.
Healthcare
|
Added | 3,207,542 | $28,899,953 | 21.43% | |
| PALI |
Palisade Bio, Inc.
Healthcare
|
Added | 11,414,285 | $19,974,998 | 14.81% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Held | 33,237 | $10,708,629 | 7.94% | |
| CLLS |
Cellectis S.A.
Healthcare
|
Held | 3,281,501 | $10,402,358 | 7.71% | |
| ZLAB |
Zai Lab Ltd
Healthcare
|
Added | 450,646 | $8,476,651 | 6.28% | |
| TSHA |
Taysha Gene Therapies, Inc.
Healthcare
|
Held | 1,800,556 | $8,048,485 | 5.97% | |
| NRXP |
NRX Pharmaceuticals, Inc.
Healthcare
|
NEW | 3,000,000 | $6,390,000 | 4.74% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Added | 127,500 | $6,145,500 | 4.56% | |
| IOVA |
Iovance Biotherapeutics, Inc.
Healthcare
|
Held | 1,500,000 | $5,265,000 | 3.90% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Held | 100,000 | $5,044,000 | 3.74% | |
| DRUG |
Bright Minds Biosciences Inc.
Healthcare
|
NEW | 67,500 | $4,925,475 | 3.65% | |
| ASMB |
Assembly Biosciences, Inc.
Healthcare
|
Held | 175,706 | $4,875,841 | 3.61% | |
| AURA |
Aura Biosciences, Inc.
Healthcare
|
Added | 597,576 | $3,997,783 | 2.96% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
Held | 75,000 | $3,678,750 | 2.73% | |
| SGHT |
Sight Sciences, Inc.
Healthcare
|
Added | 970,000 | $3,656,900 | 2.71% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
Held | 135,000 | $2,828,250 | 2.10% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
Reduced | 7,500 | $631,275 | 0.47% | |
| FHTX |
Foghorn Therapeutics Inc.
Healthcare
|
NEW | 102,000 | $487,560 | 0.36% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
NEW | 7,500 | $251,100 | 0.19% | |
| REPL |
Replimune Group, Inc.
Healthcare
|
Reduced | 26,000 | $198,900 | 0.15% |